SOURCE: VisualMED Clinical Solutions Corp.

August 09, 2007 17:48 ET

Burt Finkelstein, D. Pharm. to Join VisualMED as Senior Pharmacist

Duties Include Supervision of VisualONCOLOGY Protocols for Client Hospitals

MONTREAL--(Marketwire - August 9, 2007) - VisualMED Clinical Solutions Corp. (the "Company") (OTCBB: VMCS) (FRANKFURT: VA6) is pleased to announce that Burt Finkelstein, D. Pharm. is joining VisualMED as Senior Pharmacist, effective immediately. Dr. Finkelstein comes to VisualMED following a career with Cardinal Health (largest provider of products and services supporting the healthcare industry) of Dublin, Ohio, where he served as Manager of Pharmacy Automation and Information Systems.

Prior to that, he was Director of Pharmacy and Management Services at Johns Hopkins Bayview Medical Center in Baltimore, Maryland. His recent responsibilities have focused on the identification and integration of pharmacy informatics tools involved in the automation of pharmacy activities with decision support software used by physicians to prescribe medication.

Dr. Finkelstein received his B.S. in Pharmacy from the University Of Connecticut School Of Pharmacy in 1972, and his Doctor of Pharmacy degree from Duquesne University in 1976. During this time he served as Assistant Professor of Pharmacy at the University of Connecticut School of Pharmacy and Medicine.

Dr. Finkelstein left the University of Connecticut in 1979 and began what would be a twenty-year relationship with the Johns Hopkins Hospitals, serving first as the Assistant Director of Pharmacy for the Pediatric and OB/GYN Divisions at Johns Hopkins Hospital, and later as Director of Pharmacy at the Hopkins Bayview Campus. During his career at Hopkins, Dr. Finkelstein was directly involved with the evaluation and integration of a number of pioneering information systems for the Hopkins system.

Dr. Finkelstein joined Cardinal Health's Pyxis business unit in 2000. His duties there included new product development, product specifications, project planning and launch, as well as marketing and customer relations for a business line that had products in more than 3000 hospitals in the US.

During his academic career, Dr. Finkelstein published a number of articles describing his work in the evaluation of new drugs, and served as both Editor and Referee for publications by both F.A. Davis & Company, and WB Saunders Company in the areas of pediatric oncology and critical care. He is the recipient of several awards, including the Upjohn Public Service Award, the Bristol Award of Duquesne University for outstanding achievement, and, during his Pharmacy Residency, the Hartford Combined Pediatric House Officers Award for Excellence in the Delivery of Health Care.

Dr. Finkelstein brings more than two decades of clinical, academic, and industry experience in pharmacy to his VisualMED position at a time when VisualMED clinical oncology components are being implemented at its first Oncology site, the Segal Cancer Center of Montreal. Dr. Finkelstein will work with Dr. Alan Brox, VisualMED staff oncologist, to oversee the completion of VisualMED protocol-driven hematology-oncology content and will be involved in the marketing of VisualMED clinical investigation components to the pharmaceutical industry.

About VisualMED oncology

The VisualONCOLOGY framework for order sets supports the prescription and documentation of any standard or experimental chemotherapeutic protocol. Protocols are loaded into the VisualMED Order set Administration module by VisualMED staff during implementation of the Clinical Information System. These are updated or modified as necessary by either VisualMED staff or interested individuals on the Oncology Service. No knowledge of computer programming is required to maintain any of the domain content contained in the protocols. The protocols contain not only the chemotherapeutic drug dosages and frequencies, but orders for IV solutions, anti-emetics, scheduled laboratory and image test examinations, blood transfusions, and related nursing activities.

Protocols may be prescribed with one or two keystrokes in many cases; in others, certain patient-specific requirements may be identified and specified during the order entry process. VisualMED decision support is applied at the time a protocol is specified. Dose modifications are recommended by the system in the setting of renal failure, abnormal liver function, and can take into account levels of abnormality of various hematological parameters, as well as patient-specific clinical parameters. The system is able to track lifetime cumulative dose for any medication, and can recommend alternative medications, if indicated, when cumulative doses have been reached. Blood product transfusion can be automatically scheduled based on laboratory results returned on examinations scheduled in the original protocol. Unique to VisualMED, abnormal physical findings or other information recorded in the patient electronic medical record can feed back on individual line items in any protocol. This functionality applies even in the event medical record notations are documented days after the protocol was originally prescribed.

Beginning on the first protocol day, the VisualMED decision-support engine reviews those medications due to be administered on that day to determine if the laboratory, demographic, and clinical conditions which applied at the time the protocol was initiated, remain true. In the event that laboratory or other conditions now exist that did not exist at the time the protocol was initially prescribed, VisualMED notifies the physician through an icon alert system prior to the administration of any medication whose dose or frequency is no longer optimum. The system then recommends alternative dosing according to the requirements in the original protocol. All prescriptions, charting, data collection, and protocol-management is performed in an entirely paperless environment.

About the Company

VisualMED Clinical Solutions Corp. is a leading provider of clinical informatics solutions that help hospitals and healthcare authorities reduce medication errors, increase personnel efficiency and bring down operating costs. One of its key components, a fully integrated Clinical Information System with decision support, is a core solution in the new agenda to promote greater patient safety and reduce the morbidity and mortality associated with medication error.

Detailed information on our company and its products is available on our web site at

Forward-Looking Statements

Except for historical information provided herein, this press release may contain information and statements of a forward-looking nature concerning the future performance of the Company. These statements are based on suppositions and uncertainties as well as on management's best possible evaluation of future events. Such factors may include, without excluding other considerations, fluctuations in quarterly results, evolution in customer demand for the Company's products and services, the impact of price pressures exerted by competitors, and general market trends or economic changes. As a result, readers are advised that actual results may differ from expected results.

Contact Information